What Happened?
Cambridge, MA-based Eleven Therapeutics Appointed Paloma Giangrande as Chief Technology Officer
About the Company
Eleven Therapeutics is at the forefront of mRNA therapeutics innovation, harnessing combinatorial chemistry, synthetic biology, and artificial intelligence to develop next-generation therapies. The company`s pipeline includes extended-release mRNA therapeutics (xRNA) targeting unmet medical needs in metabolic, hematologic, and infectious disease areas. Proprietary high-throughput screening platforms, TERA™ and DELiveri™, underpin Eleven Therapeutics` pipeline by generating chemically modified xRNAs and cell-penetrating delivery carriers. Founded in 2020 by world-leading scientists across Cambridge (UK), Boston (US), and Tel Aviv (Israel), Eleven Therapeutics is supported by top-tier venture capitalists and the Bill & Melinda Gates Foundation.
About the Person
Paloma Giangrande is Chief Technology Officer at Eleven Therapeutics. Previously, Paloma held various senior IT leadership roles in the industry.
Info Source
News
Short Profile